ELLIOTTE MOSS: Open Payments
NPI 1548245632 · FARMINGTON HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 29 payments from 10 companies in 2025. Trend: 2023 $1,133 · 2024 $592 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $120 |
| GlaxoSmithKline, LLC. | 6 | $98 |
| Lilly USA, LLC | 4 | $78 |
| ABBVIE INC. | 4 | $72 |
| Amgen Inc. | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Eisai Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
Products named: Ozempic, TRELEGY ELLIPTA, OFEV, UBRELVY, QULIPTA, MOUNJARO, JARDIANCE, LEQVIO.
Industry payments across MI — which companies pay providers there.
